Fluvastatin Versus Hepatitis C Virus

• Status: Completed
• Trial end date: 2007-09-01
• Target enrollment: 0
• Participant gender: All

Summary

This is a dose finding and efficacy trial for fluvastatin versus hepatitis C.

• Phase: N/A
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Bader, Ted, M.D.
• Collaborators: US Department of Veterans Affairs; VA Office of Research and Development
• Treatments: Fluvastatin

Criteria

Inclusion Criteria:

• HCV RNA positive

Exclusion Criteria:

• Testing positive for alcohol or marijuana